GENNEXPharmaceuticals
Gennex Laboratories Ltd — Balance Sheet
₹7.13
-11.88%
Gennex Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 22.74 Cr | 22.74 Cr | 17.66 Cr | 13.26 Cr | — |
| Share Issued | 22.74 Cr | 22.74 Cr | 17.66 Cr | 13.26 Cr | — |
| Net Debt | 9.67 Cr | 5.24 Cr | 3.13 Cr | 2.63 Cr | — |
| Total Debt | 10.22 Cr | 18.94 Cr | 17.34 Cr | 10.12 Cr | — |
| Tangible Book Value | 183.75 Cr | 167.44 Cr | 74.24 Cr | 43.82 Cr | — |
| Invested Capital | 196.91 Cr | 189.32 Cr | 97.69 Cr | 53.94 Cr | — |
| Working Capital | 136.58 Cr | 121.51 Cr | 19.17 Cr | 22.97 Cr | — |
| Net Tangible Assets | 183.75 Cr | 167.44 Cr | 74.24 Cr | 43.82 Cr | — |
| Common Stock Equity | 186.69 Cr | 170.38 Cr | 80.35 Cr | 43.82 Cr | — |
| Total Capitalization | 186.69 Cr | 183.60 Cr | 96.64 Cr | 43.82 Cr | — |
| Total Equity Gross Minority Interest | 194.59 Cr | 176.46 Cr | 86.52 Cr | 43.82 Cr | — |
| Minority Interest | 7.90 Cr | 6.08 Cr | 6.17 Cr | 0.00 | — |
| Stockholders Equity | 186.69 Cr | 170.38 Cr | 80.35 Cr | 43.82 Cr | — |
| Other Equity Interest | 5.72 Cr | 6.74 Cr | 0.78 Cr | 0.78 Cr | — |
| Capital Stock | 22.74 Cr | 22.74 Cr | 18.02 Cr | 12.65 Cr | — |
| Common Stock | 22.74 Cr | 22.74 Cr | 18.02 Cr | 12.65 Cr | — |
| Total Liabilities Net Minority Interest | 61.45 Cr | 53.52 Cr | 45.80 Cr | 24.21 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 16.89 Cr | 13.22 Cr | 16.29 Cr | 32429.00 | — |
| Non Current Deferred Revenue | 0.00 | 0.00 | — | 0.00 | — |
| Non Current Deferred Taxes Liabilities | 0.00 | 0.00 | 0.00 | 32429.00 | — |
| Long Term Debt And Capital Lease Obligation | 0.00 | 13.22 Cr | 16.29 Cr | 0.00 | — |
| Long Term Debt | 0.00 | 13.22 Cr | 16.29 Cr | 0.00 | — |
| Current Liabilities | 44.55 Cr | 40.30 Cr | 29.51 Cr | 24.21 Cr | — |
| Current Debt And Capital Lease Obligation | 10.22 Cr | 5.72 Cr | 1.05 Cr | 10.12 Cr | — |
| Current Debt | 10.22 Cr | 5.72 Cr | 1.05 Cr | 10.12 Cr | — |
| Current Provisions | 0.59 Cr | 0.45 Cr | 0.61 Cr | 0.63 Cr | — |
| Payables | 20.93 Cr | 20.73 Cr | 10.60 Cr | 9.83 Cr | — |
| Total Tax Payable | 7.77 Cr | 5.26 Cr | 3.38 Cr | 2.08 Cr | — |
| Accounts Payable | 13.16 Cr | 15.18 Cr | 7.08 Cr | 7.74 Cr | — |
| Total Assets | 256.04 Cr | 229.99 Cr | 132.32 Cr | 68.03 Cr | — |
| Total Non Current Assets | 74.91 Cr | 68.17 Cr | 83.63 Cr | 20.84 Cr | — |
| Other Non Current Assets | 9.95 Cr | 8.87 Cr | 8.87 Cr | 1.00 | — |
| Non Current Deferred Taxes Assets | 0.18 Cr | 0.23 Cr | 0.14 Cr | 0.00 | — |
| Other Investments | 0.01 Cr | — | — | — | — |
| Investmentin Financial Assets | 0.00 | 0.01 Cr | 0.01 Cr | 0.01 Cr | — |
| Long Term Equity Investment | 0.00 | 0.00 | 0.00 | 6.82 Cr | — |
| Investment Properties | 0.00 | 0.00 | — | 0.00 | — |
| Goodwill And Other Intangible Assets | 2.94 Cr | 2.94 Cr | 6.11 Cr | 0.00 | — |
| Other Intangible Assets | 2.94 Cr | 2.94 Cr | — | — | — |
| Goodwill | 0.00 | 0.00 | — | 0.00 | — |
| Net PPE | 61.83 Cr | 55.24 Cr | 67.86 Cr | 13.70 Cr | — |
| Gross PPE | 61.83 Cr | 74.90 Cr | 85.42 Cr | 30.61 Cr | — |
| Construction In Progress | 5.22 Cr | 2.32 Cr | 0.02 Cr | 0.00 | — |
| Other Properties | 56.61 Cr | 8.87 Cr | 8.87 Cr | — | — |
| Current Assets | 181.13 Cr | 161.81 Cr | 48.68 Cr | 47.18 Cr | — |
| Other Current Assets | 4.69 Cr | 0.84 Cr | 0.67 Cr | -1.00 | — |
| Inventory | 35.94 Cr | 25.17 Cr | 15.69 Cr | 7.74 Cr | — |
| Other Receivables | 70.77 Cr | 14.13 Cr | 5.46 Cr | 18.64 Cr | — |
| Accounts Receivable | 14.16 Cr | 17.81 Cr | 9.42 Cr | 11.31 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 55.57 Cr | 60.23 Cr | 14.21 Cr | 7.49 Cr | — |
| Other Short Term Investments | 55.02 Cr | 115.79 Cr | 14.50 Cr | 26.90 Cr | — |
| Cash And Cash Equivalents | 0.55 Cr | 60.23 Cr | 14.21 Cr | 7.49 Cr | — |
| Retained Earnings | — | 39.95 Cr | 29.75 Cr | 23.66 Cr | 19.55 Cr |
| Additional Paid In Capital | — | 100.22 Cr | 31.07 Cr | 6.00 Cr | 6.00 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.45 Cr | 0.61 Cr | 0.63 Cr | 0.56 Cr |
| Other Payable | — | 0.28 Cr | 0.14 Cr | 0.01 Cr | — |
| Non Current Prepaid Assets | — | 0.88 Cr | 0.65 Cr | 0.32 Cr | 0.28 Cr |
| Available For Sale Securities | — | 0.01 Cr | 0.01 Cr | 0.01 Cr | 0.01 Cr |
| Investmentsin Associatesat Cost | — | 0.00 | 0.00 | 6.82 Cr | 6.82 Cr |
| Accumulated Depreciation | — | -19.65 Cr | -17.56 Cr | -16.92 Cr | -16.22 Cr |
| Machinery Furniture Equipment | — | 40.68 Cr | 48.51 Cr | 20.17 Cr | 19.90 Cr |
| Buildings And Improvements | — | 12.03 Cr | 16.54 Cr | 2.03 Cr | 2.03 Cr |
| Land And Improvements | — | 11.00 Cr | 11.48 Cr | 8.42 Cr | 8.42 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.74 Cr | 0.85 Cr | 0.82 Cr | 0.87 Cr |
| Prepaid Assets | — | 41.82 Cr | 2.17 Cr | 0.87 Cr | 0.61 Cr |
| Other Inventories | — | 0.04 Cr | 0.02 Cr | 0.02 Cr | 0.02 Cr |
| Finished Goods | — | 11.14 Cr | 7.19 Cr | 1.15 Cr | 1.07 Cr |
| Work In Process | — | 10.32 Cr | 5.24 Cr | 4.28 Cr | 2.46 Cr |
| Raw Materials | — | 3.68 Cr | 3.24 Cr | 2.28 Cr | 1.48 Cr |
| Taxes Receivable | — | 1.06 Cr | 0.21 Cr | 0.31 Cr | 0.49 Cr |
| Allowance For Doubtful Accounts Receivable | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Accounts Receivable | — | 17.81 Cr | 9.42 Cr | 11.31 Cr | 8.95 Cr |
| Cash Equivalents | — | 40.00 Cr | 0.00 | — | — |
| Cash Financial | — | 20.23 Cr | 14.21 Cr | 7.49 Cr | 0.19 Cr |
| Other Non Current Liabilities | — | — | — | -1000.00 | 1000.00 |
| Other Current Liabilities | — | — | — | — | 2.92 Cr |
| Current Deferred Taxes Liabilities | — | — | — | — | 0.02 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Gennex Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.